SEC Filing: AstraZeneca - Losec/Prilosec (omeprazole) European Commission case
MLex Summary: AstraZeneca has announced in a filing to investors that the European Commission counter-appealed a court ruling that confirmed it had abused its market position concerning the drug Losec, but which withdrew Norway and...To view the full article, register now.
Already a subscriber? Click here to view full article